On December 14, 2023 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, reported that it will present an overview of its business and provide updates on its clinical programs at Biotech Showcase, taking place January 8-10, 2024 in San Francisco, California in parallel to the 42nd Annual J.P. Morgan Healthcare Conference ("JPM Week 2024") (Press release, Anixa Biosciences, DEC 14, 2023, View Source [SID1234638560]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of Anixa’s Biotech Showcase presentation are as follows:

Date:

Tuesday, January 9, 2024

Time:

11:00 AM PST

Location:

Hilton San Francisco – Union Square (333 O’Farrell Street)

Track:

Yosemite A (Ballroom Level)

Anixa management will also be available for one-on-one meetings in San Francisco throughout JPM Week 2024.